primary antibodies against p-creb s133 Search Results


97
Cell Signaling Technology Inc p creb s133
P Creb S133, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/Phospho-CREB+(Ser133)+Rabbit+mAb/pmc06020773-3-0-4
Average 97 stars, based on 1 article reviews
p creb s133 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology p creb s133
Effect of the RA-induced differentiation on DRD1 level, PKA activity, <t>p-CREB</t> <t>S133</t> , Arc, and BDNF intracellular level/secretion in SH-SY5Y cells. In cultures treated or not with RA (10µM) were determined: a ) The DRD1 level (immunoblot at the bottom); each bar represents the mean ± SEM of DRD1/β-actin ratio from three independent experiments. b ) The PKA activity level; each bar represents the mean ± SEM of Relative activity kinase from three independent experiments in duplicates. c ) The nuclear expression level of p-CREB S133 (immunoblot at the bottom); each bar represents the mean ± SEM of p-CREB S133 /Lamin B ratio from three independent experiments, *** p < 0.001 statistical difference compared RA treatment to w/o treatment. d ) The expression level of Arc (immunoblot at the bottom); each bar represents the mean ± SEM of Arc/β-actin ratio from three independent experiments, * p < 0.05 statistical difference compared RA treatment to w/o treatment. The BDNF ( e ) intracellular and ( f ) secreted level, each bar represents the mean ± SEM of BDNF from three independent experiments by duplicate, ** p < 0.01 and **** p < 0.0001 statistical differences compared RA treatment to w/o treatment. Data were analyzed by t-student test
P Creb S133, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/p-CREB-1+Antibody/pmc11602804-31-35-44
Average 94 stars, based on 1 article reviews
p creb s133 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
PTM Biolabs anti-p-creb (s133
Effect of the RA-induced differentiation on DRD1 level, PKA activity, <t>p-CREB</t> <t>S133</t> , Arc, and BDNF intracellular level/secretion in SH-SY5Y cells. In cultures treated or not with RA (10µM) were determined: a ) The DRD1 level (immunoblot at the bottom); each bar represents the mean ± SEM of DRD1/β-actin ratio from three independent experiments. b ) The PKA activity level; each bar represents the mean ± SEM of Relative activity kinase from three independent experiments in duplicates. c ) The nuclear expression level of p-CREB S133 (immunoblot at the bottom); each bar represents the mean ± SEM of p-CREB S133 /Lamin B ratio from three independent experiments, *** p < 0.001 statistical difference compared RA treatment to w/o treatment. d ) The expression level of Arc (immunoblot at the bottom); each bar represents the mean ± SEM of Arc/β-actin ratio from three independent experiments, * p < 0.05 statistical difference compared RA treatment to w/o treatment. The BDNF ( e ) intracellular and ( f ) secreted level, each bar represents the mean ± SEM of BDNF from three independent experiments by duplicate, ** p < 0.01 and **** p < 0.0001 statistical differences compared RA treatment to w/o treatment. Data were analyzed by t-student test
Anti P Creb (S133, supplied by PTM Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/anti+p+creb++s133/pmc11505556-106-61-64
Average 90 stars, based on 1 article reviews
anti-p-creb (s133 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
fluidigm 3165009a
Whole blood phosphoflow panel 1
3165009a, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/Anti-pCREB+%5BS133%5D+(87G3)-165Ho/pmc09991871-35-9-8
Average 94 stars, based on 1 article reviews
3165009a - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc rabbit anti p creb s133
Prenatal MeHg exposure stimulates <t>CREB</t> activity specifically in RGPs (A) Dot plot of downstream CREB target genes ( Jund , Fos , Dusp1 , Egr1 ) and their expression from scRNA-seq data in RGP1 and RGP2 cell populations for control (0ppm) and 0.2ppm MeHg groups. (B) Violin plot from scRNA-seq showing Fos (upper panels) and Jund (lower panels) expressions in RGP1 and RGP2 cell populations in control (0ppm) and 0.2ppm MeHg treatment groups, n > 800 cells for each group, Mann–Whitney U test, ∗∗∗∗p < 0.0001, ns (non-significant). (C) Schematic of cortical percussors isolated from E11-12 CD1 mice, created with BioRender.com . Cells were exposed to 0 nM (control) or 250 nM MeHg with no metformin or metformin (500 μM) for 4 h, at which point they were lysed for western blot or PLA analysis. (D–I) Western blot analysis of E12 cortical precursors cultured for 4 hours in the absence or presence of 250 nM MeHg. (D, G) Blots images were probed for pS133-CREB (D), pT410/403-aPKC (G), total CREB (D), total aPKC (G) and GAPDH (D, G) as a loading control. (E-F) Quantitative analysis of pS133-CREB (E) and total CREB (F) over GAPDH. n = 5 independent experiments, Student’s t test, ∗p < 0.05, ns (non-significant) (H-I) Quantitative analysis of pT410/403-aPKC(H) and aPKC (I) over GAPDH, n = 4 independent experiments, Student’s t test, ∗p < 0.05, ns (non-significant). (J) Images of PLA + interactions (lower panels, red) between pS133-CREB and CBP, counterstained with Hoechst (blue) in cultured cortical precursors of four treatment groups i) control (0ppm MeHg and 0 μM metformin), ii) 250 nM MeHg, iii) 500 μM metformin, and iv) co-treatment of 500 μM metformin +250 nM MeHg, scale bar: 5 μm. Images of negative control PLA (upper panels) in the absence of anti-pS133-CREB and anti-CBP (upper left) or absence of PLA probes (upper right). (K) Quantitative analysis of pS133- CREB and CBP interaction signals (red) within nuclei (blue). n = 100 cells/group, n = 4 independent experiments, two-way ANOVA (group × metformin interaction F(1, 396) = 11.34, p = 0.0008, group F(1, 396) = 1.463, p = 0.2272, metformin F(1, 396) = 25.01, p < 0.0001, n = 400) with post hoc test, ∗p < 0.05, ∗∗p < 0.01. Error bars indicate the standard error of the mean (SEM). See also <xref ref-type=Figure S6 . " width="250" height="auto" />
Rabbit Anti P Creb S133, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/Met+XP+Rabbit+mAb/pmc09947313-33-0-6
Average 95 stars, based on 1 article reviews
rabbit anti p creb s133 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
ABclonal Biotechnology p creb
Fig. 5. Changes in apoptosis-related proteins expression in SH-SY5Y cells exposed to maneb. (A, B) Expression levels of mitochondrial apoptosis pathway-related proteins in SH-SY5Y cells following maneb exposure. (C, D) Expression levels of <t>PKA/CREB</t> signaling pathway-related proteins in SH-SY5Y cells following maneb exposure. Data are presented as mean ± SEM, n = 4, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
P Creb, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/Phospho-CREB1-S133+Rabbit+pAb/pm36563597-58-37-38
Average 95 stars, based on 1 article reviews
p creb - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc rabbit anti pcreb
Fig. 5. Changes in apoptosis-related proteins expression in SH-SY5Y cells exposed to maneb. (A, B) Expression levels of mitochondrial apoptosis pathway-related proteins in SH-SY5Y cells following maneb exposure. (C, D) Expression levels of <t>PKA/CREB</t> signaling pathway-related proteins in SH-SY5Y cells following maneb exposure. Data are presented as mean ± SEM, n = 4, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
Rabbit Anti Pcreb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/Phospho-CREB+(Ser133)+Rabbit+mAb/pmc07206130-250-62-66
Average 94 stars, based on 1 article reviews
rabbit anti pcreb - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Boster Bio phospho creb
Fig. 5. Changes in apoptosis-related proteins expression in SH-SY5Y cells exposed to maneb. (A, B) Expression levels of mitochondrial apoptosis pathway-related proteins in SH-SY5Y cells following maneb exposure. (C, D) Expression levels of <t>PKA/CREB</t> signaling pathway-related proteins in SH-SY5Y cells following maneb exposure. Data are presented as mean ± SEM, n = 4, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
Phospho Creb, supplied by Boster Bio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/Human+TuBB3+Recombinant+Protein/pmc04630782-179-41-51
Average 96 stars, based on 1 article reviews
phospho creb - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

92
fluidigm anti pcreb s133 87g3 176yb
Antibodies used in this study.
Anti Pcreb S133 87g3 176yb, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/Anti-pCREB+%5BS133%5D+(87G3)--176Yb/pmc07906154-15-0-4
Average 92 stars, based on 1 article reviews
anti pcreb s133 87g3 176yb - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

96
PhosphoSolutions rabbit anti pcreb s133
Antibodies used in this study.
Rabbit Anti Pcreb S133, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/Anti-CREB+(Ser133)+Antibody/pm31216095-159-7-10
Average 96 stars, based on 1 article reviews
rabbit anti pcreb s133 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

92
Novus Biologicals p creb s133
Primary antibodies used in the present study.
P Creb S133, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/CREB+%5Bp+Ser133%5D+Antibody+(SR1800)/pmc08103519-5-0-5
Average 92 stars, based on 1 article reviews
p creb s133 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Merck KGaA mouse anti-pcreb (s133) 10e9
Primary antibodies used in the present study.
Mouse Anti Pcreb (S133) 10e9, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p-creb+s133/mouse+anti+pcreb++s133++10e9/pmc04652078-121-49-54
Average 90 stars, based on 1 article reviews
mouse anti-pcreb (s133) 10e9 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Effect of the RA-induced differentiation on DRD1 level, PKA activity, p-CREB S133 , Arc, and BDNF intracellular level/secretion in SH-SY5Y cells. In cultures treated or not with RA (10µM) were determined: a ) The DRD1 level (immunoblot at the bottom); each bar represents the mean ± SEM of DRD1/β-actin ratio from three independent experiments. b ) The PKA activity level; each bar represents the mean ± SEM of Relative activity kinase from three independent experiments in duplicates. c ) The nuclear expression level of p-CREB S133 (immunoblot at the bottom); each bar represents the mean ± SEM of p-CREB S133 /Lamin B ratio from three independent experiments, *** p < 0.001 statistical difference compared RA treatment to w/o treatment. d ) The expression level of Arc (immunoblot at the bottom); each bar represents the mean ± SEM of Arc/β-actin ratio from three independent experiments, * p < 0.05 statistical difference compared RA treatment to w/o treatment. The BDNF ( e ) intracellular and ( f ) secreted level, each bar represents the mean ± SEM of BDNF from three independent experiments by duplicate, ** p < 0.01 and **** p < 0.0001 statistical differences compared RA treatment to w/o treatment. Data were analyzed by t-student test

Journal: Neurochemical Research

Article Title: Dopamine D1-Like Receptor Stimulation Induces CREB, Arc, and BDNF Dynamic Changes in Differentiated SH-SY5Y Cells

doi: 10.1007/s11064-024-04293-8

Figure Lengend Snippet: Effect of the RA-induced differentiation on DRD1 level, PKA activity, p-CREB S133 , Arc, and BDNF intracellular level/secretion in SH-SY5Y cells. In cultures treated or not with RA (10µM) were determined: a ) The DRD1 level (immunoblot at the bottom); each bar represents the mean ± SEM of DRD1/β-actin ratio from three independent experiments. b ) The PKA activity level; each bar represents the mean ± SEM of Relative activity kinase from three independent experiments in duplicates. c ) The nuclear expression level of p-CREB S133 (immunoblot at the bottom); each bar represents the mean ± SEM of p-CREB S133 /Lamin B ratio from three independent experiments, *** p < 0.001 statistical difference compared RA treatment to w/o treatment. d ) The expression level of Arc (immunoblot at the bottom); each bar represents the mean ± SEM of Arc/β-actin ratio from three independent experiments, * p < 0.05 statistical difference compared RA treatment to w/o treatment. The BDNF ( e ) intracellular and ( f ) secreted level, each bar represents the mean ± SEM of BDNF from three independent experiments by duplicate, ** p < 0.01 and **** p < 0.0001 statistical differences compared RA treatment to w/o treatment. Data were analyzed by t-student test

Article Snippet: PVDF was blocked with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-Tween) for 1 h. Membranes were incubated overnight at 4 °C with antibodies against Syn (1:1000), DRD1 (1:1000), Arc (1:500), BDNF (1:1000), p-CREB S133 (1:500), β-actin (1:5000), and Lamin B1 (1:500) (Santa Cruz Biotech., Santa Cruz, CA, USA). β-actin and Lamin B1 antibodies were used as a total and nuclear loading control, respectively.

Techniques: Activity Assay, Western Blot, Expressing

Effects of dopamine D1-like receptor activation on p-CREB S133 level,Arc level,and BDNF secretion. a ) A representative immunoblot of p-CREB S133 and Lamin B is at the bottom of the graphic; each bar represents the mean ± SEM of the p-CREB S133 /Lamin B ratio from three independent experiments, * p < 0.05 statistical difference compared cells stimulated with SKF-38393 (10 µM) (0.5 h) to cells w/o stimulation (F = 6.517). b ) A representative immunoblot of the Arc and β-actin level is at the bottom of the graphic. Each bar represents the mean ± SEM of the Arc/Actin ratio from three independent experiments, * p < 0.05 statistical difference compared cells stimulated with SKF-38393 (0.25 and 6 h) to cells non-stimulated (F = 4.378). c ) ELISA determined the BDNF secretion; each bar represents the mean ± SEM of three independent experiments by duplicated, * p < 0.05 statistical difference compared cells stimulated with SKF-38393 (6 and 24 h) to cells w/o stimulation. Results in a ) and b ) were analyzed using a one-way ANOVA test and Dunnet´s post hoc tests. Results of c ) were analyzed using a two-way ANOVA test and Tukey´s post hoc test

Journal: Neurochemical Research

Article Title: Dopamine D1-Like Receptor Stimulation Induces CREB, Arc, and BDNF Dynamic Changes in Differentiated SH-SY5Y Cells

doi: 10.1007/s11064-024-04293-8

Figure Lengend Snippet: Effects of dopamine D1-like receptor activation on p-CREB S133 level,Arc level,and BDNF secretion. a ) A representative immunoblot of p-CREB S133 and Lamin B is at the bottom of the graphic; each bar represents the mean ± SEM of the p-CREB S133 /Lamin B ratio from three independent experiments, * p < 0.05 statistical difference compared cells stimulated with SKF-38393 (10 µM) (0.5 h) to cells w/o stimulation (F = 6.517). b ) A representative immunoblot of the Arc and β-actin level is at the bottom of the graphic. Each bar represents the mean ± SEM of the Arc/Actin ratio from three independent experiments, * p < 0.05 statistical difference compared cells stimulated with SKF-38393 (0.25 and 6 h) to cells non-stimulated (F = 4.378). c ) ELISA determined the BDNF secretion; each bar represents the mean ± SEM of three independent experiments by duplicated, * p < 0.05 statistical difference compared cells stimulated with SKF-38393 (6 and 24 h) to cells w/o stimulation. Results in a ) and b ) were analyzed using a one-way ANOVA test and Dunnet´s post hoc tests. Results of c ) were analyzed using a two-way ANOVA test and Tukey´s post hoc test

Article Snippet: PVDF was blocked with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-Tween) for 1 h. Membranes were incubated overnight at 4 °C with antibodies against Syn (1:1000), DRD1 (1:1000), Arc (1:500), BDNF (1:1000), p-CREB S133 (1:500), β-actin (1:5000), and Lamin B1 (1:500) (Santa Cruz Biotech., Santa Cruz, CA, USA). β-actin and Lamin B1 antibodies were used as a total and nuclear loading control, respectively.

Techniques: Activation Assay, Western Blot, Enzyme-linked Immunosorbent Assay

Blocking the dopamine D1-like receptor inhibits the Arc, BDNF, and p-CREB S133 induction. After the pretreatment with antagonist SCH-23390 (10µM), the cells were stimulated with agonist SKF-38393 (10 µM) at maximum induction time for each parameter. a ) A representative immunoblot of p-CREB S133 and Lamin B levels is at the bottom of the graphic; each bar represents the mean ± SEM of p-CREB S133 /Lamin B ratio from three independent experiments, ** p < 0.01 statistical difference compared cells stimulated with SKF-38393 (0.5 h) to cells w/o stimulation, and && p < 0.01 cells treated with SCH-23390 + SKF-38393 to cells stimulated with SKF-38393. b ) A representative immunoblot of Arc and β-Actin level is at the bottom of the graphic; each bar represents the mean ± SEM of the Arc/β-Actin ratio from three independent experiments, ** p < 0.01 statistical difference compared cells stimulated with SKF-38393 (0.25 and 6 h) to cells w/o stimulation, and & p < 0.05 statistical difference compared cells treated with SCH-23390 + SKF-38393 (6 h) to cells stimulated with SKF-38393 (6 h) (F = v4.564 for 0.25 min and F = 14.98 for 6 h). c ) The BDNF secretion level determined by ELISA, each bar represents the mean ± SEM from three independent experiments by duplicated, * p < 0.05 statistical difference compared cells stimulated with SKF-38393 to cells w/o stimulation (F = 11.52). Data were analyzed using a t -test or one-way ANOVA test followed by a Tukey post hoc test

Journal: Neurochemical Research

Article Title: Dopamine D1-Like Receptor Stimulation Induces CREB, Arc, and BDNF Dynamic Changes in Differentiated SH-SY5Y Cells

doi: 10.1007/s11064-024-04293-8

Figure Lengend Snippet: Blocking the dopamine D1-like receptor inhibits the Arc, BDNF, and p-CREB S133 induction. After the pretreatment with antagonist SCH-23390 (10µM), the cells were stimulated with agonist SKF-38393 (10 µM) at maximum induction time for each parameter. a ) A representative immunoblot of p-CREB S133 and Lamin B levels is at the bottom of the graphic; each bar represents the mean ± SEM of p-CREB S133 /Lamin B ratio from three independent experiments, ** p < 0.01 statistical difference compared cells stimulated with SKF-38393 (0.5 h) to cells w/o stimulation, and && p < 0.01 cells treated with SCH-23390 + SKF-38393 to cells stimulated with SKF-38393. b ) A representative immunoblot of Arc and β-Actin level is at the bottom of the graphic; each bar represents the mean ± SEM of the Arc/β-Actin ratio from three independent experiments, ** p < 0.01 statistical difference compared cells stimulated with SKF-38393 (0.25 and 6 h) to cells w/o stimulation, and & p < 0.05 statistical difference compared cells treated with SCH-23390 + SKF-38393 (6 h) to cells stimulated with SKF-38393 (6 h) (F = v4.564 for 0.25 min and F = 14.98 for 6 h). c ) The BDNF secretion level determined by ELISA, each bar represents the mean ± SEM from three independent experiments by duplicated, * p < 0.05 statistical difference compared cells stimulated with SKF-38393 to cells w/o stimulation (F = 11.52). Data were analyzed using a t -test or one-way ANOVA test followed by a Tukey post hoc test

Article Snippet: PVDF was blocked with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-Tween) for 1 h. Membranes were incubated overnight at 4 °C with antibodies against Syn (1:1000), DRD1 (1:1000), Arc (1:500), BDNF (1:1000), p-CREB S133 (1:500), β-actin (1:5000), and Lamin B1 (1:500) (Santa Cruz Biotech., Santa Cruz, CA, USA). β-actin and Lamin B1 antibodies were used as a total and nuclear loading control, respectively.

Techniques: Blocking Assay, Western Blot, Enzyme-linked Immunosorbent Assay

Effects of dopamine D1-like receptor on p-CREB S133 and Arc location . After blocking (or not) the D1-like receptor, the cells were stimulated with SKF-38393 (10 µM) at indicated times. ( a ) After thirty minutes of stimulation, the p-CREB S133 location was immunodetected with an antibody against phosphorylated CREB in Ser − 133 (green); the F-actin was labeled with TRITC-phalloidin (red), and the nucleus was stained by DAPI (blue). For SKF-38,393 (10 µM), the yellow arrowheads indicate the prominent location of p-CREB S133 concurring in the nucleus visualized by the white circles in the merge column. ( b ) After fifteen minutes or six hours of stimulation, the Arc location was detected by immunofluorescence labeling Arc protein (green); the F-actin was labeled using TRITC-phalloidin (red); the nucleus was stained by DAPI (blue). An area (white dotted square) was magnified. The white arrow/squares point out the clusters of Arc near the cell membrane and lamellipodial F-actin structures without colors overlapping in merge at 0.25 h. In contrast, at 6 h, the white arrowheads point out the yellow dots corresponding to Arc location (green) overlapping with F-actin (red)

Journal: Neurochemical Research

Article Title: Dopamine D1-Like Receptor Stimulation Induces CREB, Arc, and BDNF Dynamic Changes in Differentiated SH-SY5Y Cells

doi: 10.1007/s11064-024-04293-8

Figure Lengend Snippet: Effects of dopamine D1-like receptor on p-CREB S133 and Arc location . After blocking (or not) the D1-like receptor, the cells were stimulated with SKF-38393 (10 µM) at indicated times. ( a ) After thirty minutes of stimulation, the p-CREB S133 location was immunodetected with an antibody against phosphorylated CREB in Ser − 133 (green); the F-actin was labeled with TRITC-phalloidin (red), and the nucleus was stained by DAPI (blue). For SKF-38,393 (10 µM), the yellow arrowheads indicate the prominent location of p-CREB S133 concurring in the nucleus visualized by the white circles in the merge column. ( b ) After fifteen minutes or six hours of stimulation, the Arc location was detected by immunofluorescence labeling Arc protein (green); the F-actin was labeled using TRITC-phalloidin (red); the nucleus was stained by DAPI (blue). An area (white dotted square) was magnified. The white arrow/squares point out the clusters of Arc near the cell membrane and lamellipodial F-actin structures without colors overlapping in merge at 0.25 h. In contrast, at 6 h, the white arrowheads point out the yellow dots corresponding to Arc location (green) overlapping with F-actin (red)

Article Snippet: PVDF was blocked with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-Tween) for 1 h. Membranes were incubated overnight at 4 °C with antibodies against Syn (1:1000), DRD1 (1:1000), Arc (1:500), BDNF (1:1000), p-CREB S133 (1:500), β-actin (1:5000), and Lamin B1 (1:500) (Santa Cruz Biotech., Santa Cruz, CA, USA). β-actin and Lamin B1 antibodies were used as a total and nuclear loading control, respectively.

Techniques: Blocking Assay, Labeling, Staining, Immunofluorescence, Membrane

Schematical representation of dynamic changes by dopamine D1-like receptor activation on p-CREB S133 , Arc, BDNF. PKA is activated once the dopamine D1-like receptor is stimulated, and CREB is phosphorylated ( p-CREB S133 ). Arc protein is increased at 15 min, suggesting preexistent mRNA translation; a second increase at 6 suggests a second cycle of transcription and translation. BDNF secretion fluctuates over time, suggesting that in addition to stimulation of secretion, at 24 h, the dopamine D1-like receptor would induce the BDNF endocytosis (scheme was created with BioRender.com )

Journal: Neurochemical Research

Article Title: Dopamine D1-Like Receptor Stimulation Induces CREB, Arc, and BDNF Dynamic Changes in Differentiated SH-SY5Y Cells

doi: 10.1007/s11064-024-04293-8

Figure Lengend Snippet: Schematical representation of dynamic changes by dopamine D1-like receptor activation on p-CREB S133 , Arc, BDNF. PKA is activated once the dopamine D1-like receptor is stimulated, and CREB is phosphorylated ( p-CREB S133 ). Arc protein is increased at 15 min, suggesting preexistent mRNA translation; a second increase at 6 suggests a second cycle of transcription and translation. BDNF secretion fluctuates over time, suggesting that in addition to stimulation of secretion, at 24 h, the dopamine D1-like receptor would induce the BDNF endocytosis (scheme was created with BioRender.com )

Article Snippet: PVDF was blocked with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-Tween) for 1 h. Membranes were incubated overnight at 4 °C with antibodies against Syn (1:1000), DRD1 (1:1000), Arc (1:500), BDNF (1:1000), p-CREB S133 (1:500), β-actin (1:5000), and Lamin B1 (1:500) (Santa Cruz Biotech., Santa Cruz, CA, USA). β-actin and Lamin B1 antibodies were used as a total and nuclear loading control, respectively.

Techniques: Activation Assay

Whole blood phosphoflow panel 1

Journal: Methods in molecular biology (Clifton, N.J.)

Article Title: Mass Cytometry Assessment of Cell Phenotypes and Signaling States in Human Whole Blood

doi: 10.1007/978-1-0716-2553-8_10

Figure Lengend Snippet: Whole blood phosphoflow panel 1

Article Snippet: 165 Ho , pCREB [S133] , 87G3 , Fluidigm 3165009A.

Techniques:

Prenatal MeHg exposure stimulates CREB activity specifically in RGPs (A) Dot plot of downstream CREB target genes ( Jund , Fos , Dusp1 , Egr1 ) and their expression from scRNA-seq data in RGP1 and RGP2 cell populations for control (0ppm) and 0.2ppm MeHg groups. (B) Violin plot from scRNA-seq showing Fos (upper panels) and Jund (lower panels) expressions in RGP1 and RGP2 cell populations in control (0ppm) and 0.2ppm MeHg treatment groups, n > 800 cells for each group, Mann–Whitney U test, ∗∗∗∗p < 0.0001, ns (non-significant). (C) Schematic of cortical percussors isolated from E11-12 CD1 mice, created with BioRender.com . Cells were exposed to 0 nM (control) or 250 nM MeHg with no metformin or metformin (500 μM) for 4 h, at which point they were lysed for western blot or PLA analysis. (D–I) Western blot analysis of E12 cortical precursors cultured for 4 hours in the absence or presence of 250 nM MeHg. (D, G) Blots images were probed for pS133-CREB (D), pT410/403-aPKC (G), total CREB (D), total aPKC (G) and GAPDH (D, G) as a loading control. (E-F) Quantitative analysis of pS133-CREB (E) and total CREB (F) over GAPDH. n = 5 independent experiments, Student’s t test, ∗p < 0.05, ns (non-significant) (H-I) Quantitative analysis of pT410/403-aPKC(H) and aPKC (I) over GAPDH, n = 4 independent experiments, Student’s t test, ∗p < 0.05, ns (non-significant). (J) Images of PLA + interactions (lower panels, red) between pS133-CREB and CBP, counterstained with Hoechst (blue) in cultured cortical precursors of four treatment groups i) control (0ppm MeHg and 0 μM metformin), ii) 250 nM MeHg, iii) 500 μM metformin, and iv) co-treatment of 500 μM metformin +250 nM MeHg, scale bar: 5 μm. Images of negative control PLA (upper panels) in the absence of anti-pS133-CREB and anti-CBP (upper left) or absence of PLA probes (upper right). (K) Quantitative analysis of pS133- CREB and CBP interaction signals (red) within nuclei (blue). n = 100 cells/group, n = 4 independent experiments, two-way ANOVA (group × metformin interaction F(1, 396) = 11.34, p = 0.0008, group F(1, 396) = 1.463, p = 0.2272, metformin F(1, 396) = 25.01, p < 0.0001, n = 400) with post hoc test, ∗p < 0.05, ∗∗p < 0.01. Error bars indicate the standard error of the mean (SEM). See also <xref ref-type=Figure S6 . " width="100%" height="100%">

Journal: iScience

Article Title: Prenatal low-dose methylmercury exposure causes premature neuronal differentiation and autism-like behaviors in a rodent model

doi: 10.1016/j.isci.2023.106093

Figure Lengend Snippet: Prenatal MeHg exposure stimulates CREB activity specifically in RGPs (A) Dot plot of downstream CREB target genes ( Jund , Fos , Dusp1 , Egr1 ) and their expression from scRNA-seq data in RGP1 and RGP2 cell populations for control (0ppm) and 0.2ppm MeHg groups. (B) Violin plot from scRNA-seq showing Fos (upper panels) and Jund (lower panels) expressions in RGP1 and RGP2 cell populations in control (0ppm) and 0.2ppm MeHg treatment groups, n > 800 cells for each group, Mann–Whitney U test, ∗∗∗∗p < 0.0001, ns (non-significant). (C) Schematic of cortical percussors isolated from E11-12 CD1 mice, created with BioRender.com . Cells were exposed to 0 nM (control) or 250 nM MeHg with no metformin or metformin (500 μM) for 4 h, at which point they were lysed for western blot or PLA analysis. (D–I) Western blot analysis of E12 cortical precursors cultured for 4 hours in the absence or presence of 250 nM MeHg. (D, G) Blots images were probed for pS133-CREB (D), pT410/403-aPKC (G), total CREB (D), total aPKC (G) and GAPDH (D, G) as a loading control. (E-F) Quantitative analysis of pS133-CREB (E) and total CREB (F) over GAPDH. n = 5 independent experiments, Student’s t test, ∗p < 0.05, ns (non-significant) (H-I) Quantitative analysis of pT410/403-aPKC(H) and aPKC (I) over GAPDH, n = 4 independent experiments, Student’s t test, ∗p < 0.05, ns (non-significant). (J) Images of PLA + interactions (lower panels, red) between pS133-CREB and CBP, counterstained with Hoechst (blue) in cultured cortical precursors of four treatment groups i) control (0ppm MeHg and 0 μM metformin), ii) 250 nM MeHg, iii) 500 μM metformin, and iv) co-treatment of 500 μM metformin +250 nM MeHg, scale bar: 5 μm. Images of negative control PLA (upper panels) in the absence of anti-pS133-CREB and anti-CBP (upper left) or absence of PLA probes (upper right). (K) Quantitative analysis of pS133- CREB and CBP interaction signals (red) within nuclei (blue). n = 100 cells/group, n = 4 independent experiments, two-way ANOVA (group × metformin interaction F(1, 396) = 11.34, p = 0.0008, group F(1, 396) = 1.463, p = 0.2272, metformin F(1, 396) = 25.01, p < 0.0001, n = 400) with post hoc test, ∗p < 0.05, ∗∗p < 0.01. Error bars indicate the standard error of the mean (SEM). See also Figure S6 .

Article Snippet: rabbit anti- p -CREB (S133) , Cell Signaling , Cat#9198S; RRID: AB_2561044.

Techniques: Activity Assay, Expressing, Control, MANN-WHITNEY, Isolation, Western Blot, Cell Culture, Negative Control

Journal: iScience

Article Title: Prenatal low-dose methylmercury exposure causes premature neuronal differentiation and autism-like behaviors in a rodent model

doi: 10.1016/j.isci.2023.106093

Figure Lengend Snippet:

Article Snippet: rabbit anti- p -CREB (S133) , Cell Signaling , Cat#9198S; RRID: AB_2561044.

Techniques: Recombinant, Proximity Ligation Assay, In Situ, Software, Microscopy

Fig. 5. Changes in apoptosis-related proteins expression in SH-SY5Y cells exposed to maneb. (A, B) Expression levels of mitochondrial apoptosis pathway-related proteins in SH-SY5Y cells following maneb exposure. (C, D) Expression levels of PKA/CREB signaling pathway-related proteins in SH-SY5Y cells following maneb exposure. Data are presented as mean ± SEM, n = 4, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Journal: Environment international

Article Title: Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms.

doi: 10.1016/j.envint.2022.107696

Figure Lengend Snippet: Fig. 5. Changes in apoptosis-related proteins expression in SH-SY5Y cells exposed to maneb. (A, B) Expression levels of mitochondrial apoptosis pathway-related proteins in SH-SY5Y cells following maneb exposure. (C, D) Expression levels of PKA/CREB signaling pathway-related proteins in SH-SY5Y cells following maneb exposure. Data are presented as mean ± SEM, n = 4, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Article Snippet: The following antibodies and reagents were used: Bax (Proteintech, 50599–2-Ig), Bcl-2 (Cell Signaling Technology, 3498S), cytochrome c (Abcam, ab133504), caspase-3 (Proteintech, 19677-1-AP), GAPDH (Proteintech, 60004-1- Ig), PKA (Proteintech, 55382-1-AP), phosphodiesterase 10A (PDE10A) (Proteintech, 18078-1-AP), CREB (Proteintech, 12208-1-AP), p-CREB (ABclonal, AP0333), COX IV (Abcam, ab16056), DAPI (Biofroxx, EZ3412B205), MAP-2 (ThermoFisher, SF254293), HRP-conjugated antirabbit IgG (BIO-RAD, 170-6515), HRP-conjugated anti-mouse IgG (BIORAD, 170-6516), Alexa Fluor 488-conjugated goat anti-mouse IgG (Invitrogen, A-11001), Cell Counting Kit-8 Viability Assay (CCK-8) (Solarbio, CK04), Apoptosis and Necrosis Assay Kit (Beyotime Biotechnology, C1056), TUNEL BrightRed Apoptosis Detection Kit (Vazyme, A113), Annexin V-FITC Apoptosis Detection Kit (Beyotime Biotechnology, C1062), Reactive Oxygen Species Assay Kit (Nanjing Jiancheng Bioengineering Institute, E004-1-1), N-acetylcysteine (NAC) (SigmaAldrich, A7250), JC-10 (Solarbio, CA1310), Dibutyryl-cAMP (dbcAMP) (Selleck, S7858).

Techniques: Expressing

Fig. 6. Maneb exposure induces apoptosis and changes the expression of apoptosis-related proteins in mouse brains. (A) TUNEL staining and immuno fluorescence of MAP-2 in mouse brain slides. Scale bars = 50 μm. (B, C) Expression levels of mitochon drial apoptosis pathway-related proteins in mouse brains following maneb exposure. (D, E) Expression levels of PKA/CREB signaling pathway-related pro teins in mouse brains following maneb exposure. Data are presented as mean ± SEM, n = 4, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Journal: Environment international

Article Title: Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms.

doi: 10.1016/j.envint.2022.107696

Figure Lengend Snippet: Fig. 6. Maneb exposure induces apoptosis and changes the expression of apoptosis-related proteins in mouse brains. (A) TUNEL staining and immuno fluorescence of MAP-2 in mouse brain slides. Scale bars = 50 μm. (B, C) Expression levels of mitochon drial apoptosis pathway-related proteins in mouse brains following maneb exposure. (D, E) Expression levels of PKA/CREB signaling pathway-related pro teins in mouse brains following maneb exposure. Data are presented as mean ± SEM, n = 4, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Article Snippet: The following antibodies and reagents were used: Bax (Proteintech, 50599–2-Ig), Bcl-2 (Cell Signaling Technology, 3498S), cytochrome c (Abcam, ab133504), caspase-3 (Proteintech, 19677-1-AP), GAPDH (Proteintech, 60004-1- Ig), PKA (Proteintech, 55382-1-AP), phosphodiesterase 10A (PDE10A) (Proteintech, 18078-1-AP), CREB (Proteintech, 12208-1-AP), p-CREB (ABclonal, AP0333), COX IV (Abcam, ab16056), DAPI (Biofroxx, EZ3412B205), MAP-2 (ThermoFisher, SF254293), HRP-conjugated antirabbit IgG (BIO-RAD, 170-6515), HRP-conjugated anti-mouse IgG (BIORAD, 170-6516), Alexa Fluor 488-conjugated goat anti-mouse IgG (Invitrogen, A-11001), Cell Counting Kit-8 Viability Assay (CCK-8) (Solarbio, CK04), Apoptosis and Necrosis Assay Kit (Beyotime Biotechnology, C1056), TUNEL BrightRed Apoptosis Detection Kit (Vazyme, A113), Annexin V-FITC Apoptosis Detection Kit (Beyotime Biotechnology, C1062), Reactive Oxygen Species Assay Kit (Nanjing Jiancheng Bioengineering Institute, E004-1-1), N-acetylcysteine (NAC) (SigmaAldrich, A7250), JC-10 (Solarbio, CA1310), Dibutyryl-cAMP (dbcAMP) (Selleck, S7858).

Techniques: Expressing, TUNEL Assay, Staining, Fluorescence

Fig. 7. Schematic diagram of the mechanisms underlying maneb-induced apoptosis. The mitochondrial apoptosis pathway (Bcl-2, Bax, cytochrome c, caspase-3) and the PKA/CREB pathway (PKA, PDE10A, CREB, p-CREB) are involved in maneb-induced apoptosis. In addition, maneb induces mitochon drial dysfunction and ROS accumulation, contributing to the neurotoxicity of maneb.

Journal: Environment international

Article Title: Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms.

doi: 10.1016/j.envint.2022.107696

Figure Lengend Snippet: Fig. 7. Schematic diagram of the mechanisms underlying maneb-induced apoptosis. The mitochondrial apoptosis pathway (Bcl-2, Bax, cytochrome c, caspase-3) and the PKA/CREB pathway (PKA, PDE10A, CREB, p-CREB) are involved in maneb-induced apoptosis. In addition, maneb induces mitochon drial dysfunction and ROS accumulation, contributing to the neurotoxicity of maneb.

Article Snippet: The following antibodies and reagents were used: Bax (Proteintech, 50599–2-Ig), Bcl-2 (Cell Signaling Technology, 3498S), cytochrome c (Abcam, ab133504), caspase-3 (Proteintech, 19677-1-AP), GAPDH (Proteintech, 60004-1- Ig), PKA (Proteintech, 55382-1-AP), phosphodiesterase 10A (PDE10A) (Proteintech, 18078-1-AP), CREB (Proteintech, 12208-1-AP), p-CREB (ABclonal, AP0333), COX IV (Abcam, ab16056), DAPI (Biofroxx, EZ3412B205), MAP-2 (ThermoFisher, SF254293), HRP-conjugated antirabbit IgG (BIO-RAD, 170-6515), HRP-conjugated anti-mouse IgG (BIORAD, 170-6516), Alexa Fluor 488-conjugated goat anti-mouse IgG (Invitrogen, A-11001), Cell Counting Kit-8 Viability Assay (CCK-8) (Solarbio, CK04), Apoptosis and Necrosis Assay Kit (Beyotime Biotechnology, C1056), TUNEL BrightRed Apoptosis Detection Kit (Vazyme, A113), Annexin V-FITC Apoptosis Detection Kit (Beyotime Biotechnology, C1062), Reactive Oxygen Species Assay Kit (Nanjing Jiancheng Bioengineering Institute, E004-1-1), N-acetylcysteine (NAC) (SigmaAldrich, A7250), JC-10 (Solarbio, CA1310), Dibutyryl-cAMP (dbcAMP) (Selleck, S7858).

Techniques:

Antibodies used in this study.

Journal: Aging (Albany NY)

Article Title: Dl-3-n-butylphthalide inhibits neuroinflammation by stimulating foxp3 and Ki-67 in an ischemic stroke model

doi: 10.18632/aging.202338

Figure Lengend Snippet: Antibodies used in this study.

Article Snippet: Anti-pCREB [S133] (87G3)-176Yb , Fluidigm , Cat# 3176005A.

Techniques:

Primary antibodies used in the present study.

Journal: Biomedicines

Article Title: Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats

doi: 10.3390/biomedicines9040425

Figure Lengend Snippet: Primary antibodies used in the present study.

Article Snippet: p-CREB S133 , Rabbit , Novus biologicals (NB110-55727) , 1:5000 (WB).

Techniques:

The effects of perampanel (PER) and GYKI 52466 (GYKI) on total Ca 2+ /cAMP response element-binding protein (CREB) expression and its S133 phosphorylation in chronic epilepsy rats. ( A ) Representative images for Western blot of CREB and its S133 phosphorylation level in the hippocampal tissues. ( B – D ) Quantifications of CREB (B), p-CREB S133 ( C ), and p-CREB/CREB ratio ( D ) in the hippocampal tissues. Open circles indicate each individual value. Horizontal bars indicate mean value. Error bars indicate SEM ( * ,# p < 0.05 vs. control (Cont) and vehicle (Veh)-treated animals, respectively; one-way ANOVA with post hoc Bonferroni’s multiple comparison).

Journal: Biomedicines

Article Title: Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats

doi: 10.3390/biomedicines9040425

Figure Lengend Snippet: The effects of perampanel (PER) and GYKI 52466 (GYKI) on total Ca 2+ /cAMP response element-binding protein (CREB) expression and its S133 phosphorylation in chronic epilepsy rats. ( A ) Representative images for Western blot of CREB and its S133 phosphorylation level in the hippocampal tissues. ( B – D ) Quantifications of CREB (B), p-CREB S133 ( C ), and p-CREB/CREB ratio ( D ) in the hippocampal tissues. Open circles indicate each individual value. Horizontal bars indicate mean value. Error bars indicate SEM ( * ,# p < 0.05 vs. control (Cont) and vehicle (Veh)-treated animals, respectively; one-way ANOVA with post hoc Bonferroni’s multiple comparison).

Article Snippet: p-CREB S133 , Rabbit , Novus biologicals (NB110-55727) , 1:5000 (WB).

Techniques: Binding Assay, Expressing, Phospho-proteomics, Western Blot, Control, Comparison

The effects of 3CAI co-treatment with perampanel (PER) and GYKI 52466 (GYKI) on expression levels of GSK3β, CREB, and PICK1 and the phosphorylation levels of GSK3β and CREB in non-responders. ( A ) Representative images for Western blot of total GSK3β, CREB, and PICK1 levels and the phosphorylation levels of GSK3β and CREB. ( B – H ) Quantifications of GSK3β ( B ), p-GSK3β S9 ( C ), p-GSK3β S9/GSK3β ratio ( D ), CREB ( E ), p-CREB S133 ( F ), p-CREB S133/CREB ratio ( G ), and PICK1 ( H ) in the hippocampal tissues. Open circles indicate each individual value. Horizontal bars indicate mean value. Error bars indicate SEM ( *, # p < 0.05 vs. control (Cont) and vehicle (Veh)-treated animals, respectively; one-way ANOVA with post hoc Bonferroni’s multiple comparison).

Journal: Biomedicines

Article Title: Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats

doi: 10.3390/biomedicines9040425

Figure Lengend Snippet: The effects of 3CAI co-treatment with perampanel (PER) and GYKI 52466 (GYKI) on expression levels of GSK3β, CREB, and PICK1 and the phosphorylation levels of GSK3β and CREB in non-responders. ( A ) Representative images for Western blot of total GSK3β, CREB, and PICK1 levels and the phosphorylation levels of GSK3β and CREB. ( B – H ) Quantifications of GSK3β ( B ), p-GSK3β S9 ( C ), p-GSK3β S9/GSK3β ratio ( D ), CREB ( E ), p-CREB S133 ( F ), p-CREB S133/CREB ratio ( G ), and PICK1 ( H ) in the hippocampal tissues. Open circles indicate each individual value. Horizontal bars indicate mean value. Error bars indicate SEM ( *, # p < 0.05 vs. control (Cont) and vehicle (Veh)-treated animals, respectively; one-way ANOVA with post hoc Bonferroni’s multiple comparison).

Article Snippet: p-CREB S133 , Rabbit , Novus biologicals (NB110-55727) , 1:5000 (WB).

Techniques: Expressing, Phospho-proteomics, Western Blot, Control, Comparison